News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,445 Results
Type
Article (5018)
Company Profile (17)
Press Release (220410)
Section
Business (82214)
Career Advice (462)
Deals (15042)
Drug Delivery (8)
Drug Development (19062)
Employer Resources (30)
FDA (3677)
Job Trends (3902)
News (120119)
Policy (7502)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14777)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (43)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (452)
Cardiovascular disease (24)
Career advice (394)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16038)
Collaboration (171)
Compensation (170)
Complete response letters (2)
COVID-19 (301)
CRISPR (8)
C-suite (108)
Cystic fibrosis (16)
Data (525)
Depression (5)
Diabetes (43)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40865)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37819)
Executive appointments (313)
FDA (3930)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (108)
Government (412)
Guidances (17)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7824)
IRA (3)
Job creations (1121)
Job search strategy (361)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (50)
MASH (28)
Medical device (3863)
Medtech (3864)
Mergers & acquisitions (7425)
Metabolic disorders (123)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (343)
NextGen: Class of 2025 (1674)
Non-profit (728)
Northern California (939)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (31)
Peanut (5)
People (24607)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6963)
Phase III (5550)
Pipeline (564)
Policy (9)
Postmarket research (625)
Preclinical (1872)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1880)
Recruiting (8)
Regulatory (5118)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (709)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
United States (7131)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (59)
Last 7 days (222)
Last 30 days (733)
Last 365 days (9955)
2025 (3124)
2024 (11032)
2023 (13198)
2022 (18662)
2021 (19685)
2020 (18248)
2019 (13211)
2018 (10207)
2017 (10009)
2016 (9169)
2015 (12136)
2014 (9596)
2013 (7723)
2012 (8338)
2011 (8808)
2010 (8641)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11485)
Australia (1610)
California (1968)
Canada (710)
China (73)
Colorado (84)
Connecticut (94)
Delaware (30)
Europe (24609)
Florida (282)
Georgia (34)
Idaho (23)
Illinois (113)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1580)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (568)
New Mexico (6)
New York (478)
North Carolina (329)
North Dakota (3)
Northern California (939)
Ohio (59)
Oklahoma (5)
Oregon (4)
Pennsylvania (349)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (709)
Tennessee (40)
Texas (229)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (175)
West Virginia (2)
Wisconsin (24)
225,445 Results for "hamamatsu corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hamamatsu Photonics and Sirona Dx (SDX) Announce Strategic Partnership to Expand Technology Access Program (TAP)
April 14, 2025
·
3 min read
Press Releases
PredxBio and Hamamatsu Photonics Announce Strategic Partnership to Deliver Next-Generation Spatial Biology Solutions for Cancer Research and Therapeutic Development
April 28, 2025
·
3 min read
Pharm Country
Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner
Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.
May 22, 2024
·
4 min read
Press Releases
Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly system for 3D cell screening assays
September 9, 2024
·
4 min read
Hamamatsu and Siemens Healthineers announce the distribution of the whole slide scanners to clinical markets
Hamamatsu announced a multi-year distribution agreement with Siemens Healthineers.
March 6, 2023
·
4 min read
Pharm Country
INFINITT announces collaboration with Hamamatsu, a leading manufacturer of whole slide scanners
INFINITT North America announced a collaboration with Hamamatsu Corporation to jointly promote Hamamatsu whole slide scanners and INFINITT Digital Pathology Solution to its United States customers.
September 20, 2022
·
3 min read
Biotech Beach
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
Agilent Technologies Inc. announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution.
March 10, 2023
·
3 min read
Business
Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows
Indica Labs and Hamamatsu Photonics K.K. announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.
October 14, 2022
·
5 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Business
Proscia and Hamamatsu Announce Collaboration to Accelerate Scaled Adoption of Digital Pathology
Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale.
March 9, 2022
·
3 min read
1 of 22,545
Next